-
Mashup Score: 0
Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD caused by RSV.
Source: www.empr.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.
Source: www.empr.comCategories: General Medicine NewsTweet-
Kerendia gains new indication; it showed a 16% reduction for CV death and total heart failure events when compared with placebo. https://t.co/L9hPwZ1Pwr https://t.co/9P0aMzOsUH
-
-
Mashup Score: 0The Grand Roundup - 2 day(s) ago
We know it can be difficult to keep up with emerging research, conference news, and guideline updates. Enter the Grand Roundup: a hyper-focused, curated
Source: www.psychiatryadvisor.comCategories: General Medicine NewsTweet-
Searching for the latest news and research about addiction disorders? Sign up for the Grand Roundup, our curated newsletter to help you stay informed on clinical topics that matter most to you: https://t.co/jNEVhYAq1D https://t.co/AuE5uEHQou
-
-
Mashup Score: 0
The USPSTF meets several times a year to review the latest science and decide which screenings, medications and other preventive services should be fully covered by insurance.
Source: www.empr.comCategories: General Medicine NewsTweet-
The meeting, which guides what medication is covered by insurance, was canceled by RFK Jr. without any reason given. https://t.co/JFTL5cR48X https://t.co/Um9XOHGUOL
-
-
Mashup Score: 0
In this month’s case, an error went unrecognized for months despite numerous opportunities for its discovery.
Source: www.empr.comCategories: General Medicine NewsTweet-
Law feature: A dispensing error goes unnoticed for months for a young girl with Wilson disease. https://t.co/U0TNsWW96J
-
-
Mashup Score: 0NIH to Cap Publishing Fees for Publicly Funded Research - 6 day(s) ago
Agency says these fees place an additional burden on taxpayers who already fund the underlying research.
Source: www.empr.comCategories: General Medicine NewsTweet-
The National Institutes of Health is putting a limit on publisher fees for publicly funded research. https://t.co/UkX0YIqV3h https://t.co/NGloxyibtN
-
-
Mashup Score: 0FDA Drug Approval Decisions Expected in August 2025 - 7 day(s) ago
The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.
Source: www.empr.comCategories: General Medicine NewsTweet-
View all the drug approval decisions expected to take place in August, 2025. https://t.co/psIB8fjgxS https://t.co/GEml7Afgfn
-
-
Mashup Score: 0Medical Groups Sue RFK Jr Over Vaccine Policy Changes - 8 day(s) ago
The lawsuit was prompted by several recent HHS actions the plaintiffs noted were “designed to mislead, confuse, and gradually desensitize the public to anti-vaccine and anti-science rhetoric.”
Source: www.empr.comCategories: General Medicine NewsTweet-
A group of plaintiffs, including the American Academy of Pediatrics, are suing HHS secretary Robert F. Kennedy. https://t.co/ko6SXTshyX https://t.co/BpuGDSK5kN
-
-
Mashup Score: 1
We spoke with Dr Kellan Baker of the Whitman-Walker institute to shed some light on the many changes taking place to various aspects of medical care for LGBTQ+ individuals.
Source: www.empr.comCategories: General Medicine NewsTweet-
Medical care for LGBTQ+ individuals is at a crossroads so we spoke to Dr Kellan E. Baker about what the future holds. https://t.co/etnqVZ7wUF
-
-
Mashup Score: 0The Grand Roundup - 9 day(s) ago
We know it can be difficult to keep up with emerging research, conference news, and guideline updates. Enter the Grand Roundup: a hyper-focused, curated
Source: www.neurologyadvisor.comCategories: General Medicine News, General Journals & SocietTweet-
Sign up today for our bi-weekly email covering emerging research, conference news, and guideline updates on neurocognitive disorders, headache and pain syndromes, and cerebrovascular diseases: https://t.co/2VHQ4eZJ1L https://t.co/7nbZSPPCeK
-
The FDA has agreed to review a proposed expansion to the indication for the RSV vaccine. https://t.co/E1dBJnVcea https://t.co/ZS3QzBytJJ